Trial Profile
Evaluation of oral antidiabetic agents efficiency of newly diagnosed diabetes: a Multicenter Open label randomized clinical trial
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Aug 2020
Price :
$35
*
At a glance
- Drugs Gliclazide (Primary) ; Metformin (Primary) ; Repaglinide (Primary) ; Saxagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 03 Nov 2016 New trial record